Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,250 shares at $79.12 ($257K) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Seasonal sale ($257k) by Chief Research Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.12 | 1,625 | $129K | 50.0% |
| 2 | $79.12 | 1,625 | $129K | 50.0% |
| Total | $79.12 avg | 3,250 | $257K | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |